- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 226
Surrozen generates $50m series B
Based on Stanford research, Surrozen is working on regenerative treatments for a wide range of conditions, with a first focus on liver disease.
Mar 22, 2019Tarana wires in $88m
AT&T and Deutsche Telekom-backed wireless internet system developer Tarana added $60m from investors including EchoStar to close the round.
Mar 22, 2019Markforged assembles $82m in series D funding
Microsoft subsidiary M12, Siemens' Next47 fund and Porsche all invested in the industrial 3D printer producer's latest round, which lifted its overall funding to $139m.
Mar 22, 2019Splice tunes into series C funding
The WME and AM Only-backed music production platform has now raised approximately $100m in total, following a $57.5m round co-led by True Ventures and USV.
Mar 22, 2019Ojo Labs gets $45m result
The real estate-focused chatbot developer has now raised more than $71m in total, having secured series C funding from investors including Realogy, Royal Bank of Canada and Northwestern Mutual.
Mar 21, 2019Mojo Vision moves to $58m series B
LG, HP Tech Ventures, Motorola Solutions Venture Capital, Kakao Ventures and Gradient Ventures all invested, four months after the AR startup's $50m series A.
Mar 20, 2019Instarem increases series C round to $41m
The financial remittance service has added $21m to more than double a series C round that included Telkom Indonesia, Kasikorn Bank, Rocket Internet and SBI.
Mar 20, 2019Mojo Vision sets $58m series B scene
Stanford-StartX has contributed to a $58m series B for AR platform Mojo Vision, which also attracted Google, HP, Motorola Solutions, LG and Kakao.
Mar 20, 2019Carro drives series B round to $90m
SoftBank Ventures Asia was among the returning investors that helped add $30m to a $60m first tranche that included Singtel Innov8.
Mar 19, 2019Imara imports $63m in series B funding
The sickle cell disease therapy developer boosted its overall funding to $94m in a round backed by Lundbeck, Pfizer and Alexandria Real Estate Equities.
Mar 19, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


